NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Managed Care Weekly Digest

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



CardiacAssist Inc.



Privately held CardiacAssist reports record revenues for nine-month financial results



November 2nd, 2009

Privately held CardiacAssist Inc. announced nine-month financial results for 2009. TandemHeart System revenues were at new record levels compared to results for the same period in 2008. FDA-cleared and CE-Marked TandemHeart can be placed rapidly by both interventional cardiologists in a cath lab and by cardiac surgeons in an operating room to provide short-term circulatory support to patients requiring additional cardiac assistance. The device provides effective and reliable temporary circulatory support for critically ill patients. Hemodynamic support includes a high net blood-flow rate of up to five liters per minute in the catheterization lab or up to eight liters per minute in the OR -...


Source: Managed Care Weekly Digest (2009-11-02)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login